Author

RM McGovern

Institutions: Mayo Clinic, Mayo Clinic in Arizona, National Cancer Institute

Observed institutions: Mayo Clinic, Mayo Clinic in Arizona, National Cancer Institute

OpenAlex ID: A5070413480

Abstract PD2-03: Final results of a first-in-human phase I study of the tamoxifen (TAM) metabolite, Z-Endoxifen hydrochloride (Z-Endx) in women with aromatase inhibitor (AI) refractory metastatic breast cancer (MBC) (NCT01327781)

2016 · MP Goetz, VJ Suman, et al. · Cancer Research · 1

Works count: 1

Citation count: 1

H-index: 1

I10-index: